Overview

Genetics of Hyperuricemia Therapy in Hmong

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
To pursue this objective, we will be measuring uric acid at baseline and post 14 days of twice daily allopurinol therapy in 30 Hmong participants with documented gout or hyperuricemia and known genotype for key renal transporters of uric acid.
Details
Lead Sponsor:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Treatments:
Allopurinol